Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Beta Blockers in Traumatic Brain Injury
NCT06836856Phase 2Recruiting
- Sponsor
- Mansoura University
- Start
- Jan 2025
- Primary completion
- Jun 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of propranolol and carvedilol in traumatic brain injury (TBI) (3 arms), sponsored by Mansoura University. Primary endpoint: Incidence of In-hospital mortality at 14 days. Started Jan 2025; status: recruiting.
02
Drugs
propranololcarvedilol
03
Conditions
traumatic brain injury (TBI)
Beyond the preview
Go deeper on NCT06836856.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06836856.